Skip to main content
Dallah Healthcare Co. logo

Dallah Healthcare Co. — Investor Relations & Filings

Ticker · 4004 ISIN · SA135G51UI10 Saudi Exchange Human health and social work activities
Filings indexed 313 across all filing types
Latest filing 2026-04-23 M&A Activity
Country SA Saudi Arabia
Listing Saudi Exchange 4004

About Dallah Healthcare Co.

http://www.dallahhealth.com

Dallah Healthcare Co. operates a network of specialized hospitals and outpatient clinics, including flagship facilities such as Dallah Hospital Al Nakheel and Dallah Hospital Namar. The company provides a broad spectrum of medical services, ranging from inpatient and outpatient care to complex surgical procedures, diagnostic imaging, and laboratory services. In addition to direct patient care, the organization is involved in the distribution of pharmaceutical products and medical supplies. Dallah Healthcare emphasizes clinical excellence and patient safety, utilizing advanced medical technologies and maintaining international quality accreditations. Its service model caters to a diverse demographic, offering specialized treatments across various medical disciplines to meet the needs of both individual and corporate clients.

Recent filings

Filing Released Lang Actions
Dallah Healthcare Company announces recent developments in relation to the acquisition of shares in Al-Ahsa Medical Services Company (Dallah Al-Ahsa Hospital)
M&A Activity Classification · 1% confidence The document is an issuer announcement on the Saudi Exchange detailing Dallah Healthcare’s completion of the acquisition of the remaining share capital of Al-Ahsa Medical Services Company. It describes the takeover bid / merger transaction’s latest developments and completion. This aligns with the M&A Activity category (Code: TAR).
2026-04-23 English
Announcement of Dallah Healthcare Company regarding the Board of Directors’ recommendation to increase the Company’s capital through Issuance of Bonus Shares
Regulatory Filings
2026-03-04 English
Dallah Healthcare Company announces the Board of Directors’ decision to distribute interim cash dividends to shareholders for the fourth quarter of 2025.
Regulatory Filings
2026-03-04 English
Dallah Healthcare Co. announces its Annual Financial results for the period ending on 2025-12-31
Regulatory Filings
2026-03-04 English
Dallah Healthcare Co. announces recent developments in relation to the purchase of all remaining stocks in Care Shield Holding Company (Kingdom Hospital and Consulting Clinics) with the value of SAR 4
Regulatory Filings
2025-12-24 English
Dallah Healthcare Company announces the purchase of all remaining stocks in Care Shield Holding Company (Kingdom Hospital and Consulting Clinics) with the value of SAR 434,311,080
Regulatory Filings
2025-12-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.